Prevent Cancer Foundation's 2025 Early Detection Survey showed that only about half of U.S. adults 21 years and older said ...

INmune Bio Inc. (NASDAQ: INMB) a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system has partnered with the Cell and Gene Therapy Catapult (CGT ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Teddi Mellencamp, who is battling stage four melanoma, revealed that her doctors have given her 50/50 odds of beating her ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Explore JANX's promising early data in prostate cancer immunotherapy. Understand market challenges, buyout rumors, and ...

Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.

Cancer Cell Swirling inside every ... back after diminishing in response to first-line therapies, like hormone therapy and radiation. The scientists measured the types and amounts of proteins present ...

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...